Related references
Note: Only part of the references are listed.Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model
Lubna Noorani et al.
JOURNAL OF NANOBIOTECHNOLOGY (2015)
Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells
Weibo Luo et al.
Oncotarget (2015)
Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer
Mary Clare Cathcart et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Scutellaria barbata inhibits angiogenesis through downregulation of HIF-1 α in lung tumor
Ai-Li Shiau et al.
ENVIRONMENTAL TOXICOLOGY (2014)
Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8
G-One Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy
Hiroshi Okumura et al.
SURGERY TODAY (2014)
Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD
Cen Zhang et al.
ONCOTARGET (2014)
Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib
W. Y. Sanchez et al.
BRITISH JOURNAL OF CANCER (2013)
The VEGF pathway in lung cancer
Michalis Alevizakos et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Metabolic preconditioning of mammalian cells: mimetic agents for hypoxia lack fidelity in promoting phosphorylation of pyruvate dehydrogenase
Apurva Borcar et al.
CELL AND TISSUE RESEARCH (2013)
Exosomes Derived from Mesenchymal Stem Cells Suppress Angiogenesis by Down-Regulating VEGF Expression in Breast Cancer Cells
Jong-Kuen Lee et al.
PLOS ONE (2013)
Critical Role of Hypoxia Sensor - HIF-1α in VEGF Gene Activation. Implications for Angiogenesis and Tissue Injury Healing
A. Ahluwalia et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo et al.
CELL (2011)
Albendazole sensitizes cancer cells to ionizing radiation
Kirtesh Patel et al.
RADIATION ONCOLOGY (2011)
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Pipsa Saharinen et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Potent inhibition of tumoral hypoxia-inducible factor 1α by albendazole
Mohammad H. Pourgholami et al.
BMC CANCER (2010)
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer
Mohammad H. Pourgholami et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
AN OUTBREAK OF ANGIOSTRONGYLIASIS CANTONENSIS IN BEIJING
Jing Wang et al.
JOURNAL OF PARASITOLOGY (2010)
A CD147-targeting siRNA inhibits the proliferation, invasiveness and VEGF production of human malignant melanoma cells by down-regulating glycolysis
Juan Su et al.
CANCER LETTERS (2009)
Taenia crassiceps: Energetic and respiratory metabolism from cysticerci exposed to praziquantel and albendazole in vitro
Marina Clare Vinaud et al.
EXPERIMENTAL PARASITOLOGY (2008)
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1 alpha
Mei Y. Koh et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
Cancer's molecular sweet tooth and the Warburg effect
Jung-whan Kim et al.
CANCER RESEARCH (2006)
Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice
MH Pourgholami et al.
CLINICAL CANCER RESEARCH (2006)
Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1 alpha independent mechanisms
M Guo et al.
APOPTOSIS (2006)
Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis
MH Pourgholami et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations
J Horton
CURRENT OPINION IN INFECTIOUS DISEASES (2002)
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
A Giatromanolaki et al.
BRITISH JOURNAL OF CANCER (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole
MH Pourgholami et al.
CANCER LETTERS (2001)
Share Paper
